A case study for calculating employer costs for lost productive time in episodic migraine and chronic migraine: Results of the American migraine prevalence and prevention study

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 10, 2011, Pages 1161-1171

  Stewart, Walter F ^a   Bruce, Christa ^a,c   Manack, Aubrey ^b   Buse, Dawn C ^d   Varon, Sepideh F ^b   Lipton, Richard B ^c,d  

^a GEISINGER MEDICAL CENTER   (United States)

^b ALLERGAN INC   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DEMOGRAPHY; EPISODIC MIGRAINE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRODUCTIVITY; TRANSFORMED MIGRAINE; UNITED STATES; WORKPLACE;

EID: 80054034885     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31822cff3c     Document Type: Article

References (41)

1. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol. 2006;5:148-157. (Pubitemid 43107850)
2. Fautrel B, Guillemin F. Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol. 2002;14:121-126. (Pubitemid 34185293)
3. Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: Composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum. 2001;44: 528-534. (Pubitemid 32234610)
4. Blaiss MS. Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc. 2000;21:7-13.
5. Blanc PD, Trupin L, Eisner M, et al. The work impact of asthma and rhinitis: Findings from a population-based survey. J Clin Epidemiol. 2001;54:610-618. (Pubitemid 32453355)
6. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The impact of allergies and allergy treatment on worker productivity. J Occup Environ Med. 2001;43:64-71. (Pubitemid 32098845)
7. Henke CJ, Levin TR, Henning JM, Potter LP. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000;95:788-792. (Pubitemid 30123921)
8. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol. 2001;96: S57-S61. (Pubitemid 32758211)
9. Berndt ER, Bailit HL, Keller MB, Verner JC, Finkelstein SN. Health care use and at-work productivity among employees with mental disorders. Health Aff (Millwood). 2000;19:244-256.
10. Stewart WF, Wood GC, Razzaghi H, Reed ML, Lipton RB. Work impact of migraine headaches. J Occup Environ Med. 2008;50:736-745.
11. Stewart WF, Ricci JA, Chee E, Morganstein D. Lost productive work time costs from health conditions in the United States: Results from the American Productivity Audit. J Occup Environ Med. 2003;45:1234-1246. (Pubitemid 37541937)
12. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349. (Pubitemid 46184209)
13. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001;41:646-657. (Pubitemid 32777747)
14. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
15. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology. 1996;47:52-59. (Pubitemid 26243858)
16. Headache Classification Subcommittee of the InternationalHeadache Society. The International Classification of Headache Disorders. 2nd ed. Cephalalgia. 2004;24(suppl 1):9-160.
17. Bureau of Labor Statistics. Adjustments to Household Survey Population Estimates in January 2007.Available at: Http://www.bls.gov/cps/cps07adj.pdf. Accessed October 3, 2009.
18. StewartWF,Wood GC,Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010;52:8-14.
19. D'Amico D, Moschiano F, Usai S, Bussone G. Treatment strategies in the acute therapy of migraine: Stratified care and early intervention. Neurol Sci. 2006;27(suppl 2):S117-S122. (Pubitemid 44390127)
20. Lipton RB, Stewart WF, Cady R, et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: Results of the Spectrum Study. Headache. 2000;40:783-791. (Pubitemid 32053238)
21. US Census Bureau. Available at: Http://www.census.gov/hhes/www/income/ data/historical/people/index.html. Accessed August 15, 2010.
22. Stewart WF, Ricci JA, Leotta C, Chee E. Validation of the work and health interview. Pharmacoeconomics. 2004;22:1127-1140. (Pubitemid 39665343)
23. Smith DJ. Absenteeism and "presenteeism" in industry. Arch Environ Health. 1970;21:670-677.
24. Berger ML, Murray JF, Xu J, Pauly M. Alternative valuations of work loss and productivity. J Occup Environ Med. 2001;43:18-24. (Pubitemid 32098840)
25. Holland J, Holland C. Impact of theWorkplace Environment onWorker Health and Productivity. Scottsdale, AZ: The Institute for Health and Productivity Management; 2001.
26. McCunney RJ. Health and productivity: A role for occupational health professionals. J Occup Environ Med. 2001;43:30-35. (Pubitemid 32098841)
27. Aldana SG, Pronk NP. Health promotion programs, modifiable health risks, and employee absenteeism. J Occup Environ Med. 2001;43:36-46. (Pubitemid 32098842)
28. Brouwer WB, Koopmanschap MA, Rutten FF. Productivity losses without absence: Measurement validation and empirical evidence. Health Policy. 1999;48:13-27. (Pubitemid 29295395)
29. Bunn WB III, Pikelny DB, Slavin TJ, Paralkar S. Health, safety, and productivity in amanufacturing environment. J Occup Environ Med. 2001;43:47-55. (Pubitemid 32098843)
30. Koopman C, PelletierKR, Murray JF, et al. Stanford presenteeism scale: Health status and employee productivity. J Occup Environ Med. 2002;44:14-20. (Pubitemid 34052802)
31. Stewart WF, Ricci JA, Leotta C. Health-related lost productive time (LPT): Recall interval and bias in LPT estimates. J Occup Environ Med. 2004;46: S12-S22. (Pubitemid 38747690)
32. StewartWF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289:3135-3144. (Pubitemid 37432889)
33. Stewart WF, Simon D, Shechter A, Lipton RB. Population variation in migraine prevalence: A meta-analysis. J Clin Epidemiol. 1995;48:269-280.
34. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management for Prevention of Migraine. Saint Paul, MN: American Academy of Neurology, 2000.
35. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med. 2002;346:257-270.
36. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebocontrolled study. Cephalalgia. 2007;27:814-823. (Pubitemid 46961730)
37. Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med. 2006;354:158-165. (Pubitemid 43076713)
38. Matchar DB, Harpole L, Samsa GP, et al. The headache management trial: A randomized study of coordinated care. Headache. 2008;48:1294-1310.
39. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of theMigraine Disability Assessment (MIDAS) score. Neurology. 1999;53:988-994. (Pubitemid 29442114)
40. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:41-52.
41. Stewart WF, Wood GC, Bruce C, Buse DC, Runken MC, Lipton RB. Longitudinal change in migraine headache-days and inderect cost consequences. J Occup Environ Med. 2011;53:478-487.